<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34734091</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression.</ArticleTitle><Pagination><StartPage>7652569</StartPage><MedlinePgn>7652569</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7652569</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/7652569</ELocationID><Abstract><AbstractText><i>Background</i>. Dengue virus (DENV) infection is the most common arboviral disease that affects tropical and subtropical regions. Based on the clinical hallmarks, the different severities of patients range from mild dengue fever (MDF) to severe dengue diseases (SDDs) and include dengue hemorrhagic fever or dengue shock syndrome. These are commonly associated with cytokine release syndrome (CRS). The types and levels of cytokines/chemokines, which are suppressed or enhanced, are varied, indicating CRS's pathogenic and host defensive effects. <i>Principal Finding</i>. In this study, we created an integrated and precise multiplex panel of cytokine/chemokine assays based on our literature analysis to monitor dengue CRS. A 24-plex panel of cytokines/chemokines was evaluated to measure the plasma levels of targeting factors in dengue patients with an MDF and SDD diagnosis without or with comorbidities. As identified in sixteen kinds of cytokines/chemokines, ten were significantly (<i>P</i> &lt; 0.05) (10/16) increased, one was significantly (<i>P</i> &lt; 0.01) (1/16) decreased, and five were potentially (5/16) altered in all dengue patients (<i>n</i> = 30) in the acute phase of disease onset. Compared to MDF, the levels of IL-8 (CXCL-8) and IL-18 in SDD were markedly (<i>P</i> &lt; 0.05) increased, accompanied by positively increased IL-6 and TNF-<i>&#x3b1;</i> and decreased IFN-<i>&#x3b3;</i> and RANTES. With comorbidities, SDD significantly (<i>P</i> &lt; 0.01) portrayed elevated IL-18 accompanied by increased IL-6 and decreased IFN-<i>&#x3b1;</i>2 and IL-12. In addition, decreased platelets were significantly (<i>P</i> &lt; 0.05) associated with increased IL-18. <i>Significance</i>. These results demonstrate an efficient panel of dengue cytokine/chemokine assays used to explore the possible level of CRS during the acute phase of disease onset; also, we are the first to report the increase of IL-18 in severe dengue with comorbidity compared to severe dengue without comorbidity and mild dengue.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Josephine Diony Nanda et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nanda</LastName><ForeName>Josephine Diony</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Chiau-Jing</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satria</LastName><ForeName>Rahmat Dani</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Laboratory Installation, Dr. Sardjito Central General Hospital, Yogyakarta 55281, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhan</LastName><ForeName>Ming-Kai</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ting-Jing</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Po-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Laboratory of Immune Monitoring, Office of Research &amp; Development, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yung-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0003-2951-6679</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Tainan Hospital, Ministry of Health and Welfare, Tainan 700, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-4396-6086</Identifier><AffiliationInfo><Affiliation>International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Laboratory of Immune Monitoring, Office of Research &amp; Development, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000589760">IL18 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020382">Interleukin-18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020382" MajorTopicYN="N">Interleukin-18</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There is no conflict of interest in the process of writing this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34734091</ArticleId><ArticleId IdType="pmc">PMC8560270</ArticleId><ArticleId IdType="doi">10.1155/2021/7652569</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S., Gething P. W., Brady O. J., et al. The global distribution and burden of dengue. Nature . 2013;496(7446):504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 
Dengue and severe dengue: World Health Organization
.  2021  https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.</Citation></Reference><Reference><Citation>World Health Organization ROfS-EA. Revised and expanded edition . WHO Regional Office for South-East Asia; 2011. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever.</Citation></Reference><Reference><Citation>Kalayanarooj S. Clinical manifestations and management of dengue/DHF/DSS. Trop Med Health. . 2011;39(4 Supplement):83&#x2013;87. doi: 10.2149/tmh.2011-S10.</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh.2011-S10</ArticleId><ArticleId IdType="pmc">PMC3317599</ArticleId><ArticleId IdType="pubmed">22500140</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal S., Reynales H., Saez-Llorens X., et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. The New England Journal of Medicine . 2019;381(21):2009&#x2013;2019. doi: 10.1056/NEJMoa1903869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1903869</ArticleId><ArticleId IdType="pubmed">31693803</ArticleId></ArticleIdList></Reference><Reference><Citation>Capeding M. R., Tran N. H., Hadinegoro S. R., et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet . 2014;384(9951):1358&#x2013;1365. doi: 10.1016/S0140-6736(14)61060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61060-6</ArticleId><ArticleId IdType="pubmed">25018116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Massad E. Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine. Expert Review of Vaccines . 2016;15(4):437&#x2013;441. doi: 10.1586/14760584.2016.1143366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1143366</ArticleId><ArticleId IdType="pubmed">26775653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.-H., Urbina A. N., Chang M. R., et al. Dengue hemorrhagic fever - a systemic literature review of current perspectives on pathogenesis, prevention and control. Journal of Microbiology, Immunology and Infection . 2020;53(6):963&#x2013;978. doi: 10.1016/j.jmii.2020.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.007</ArticleId><ArticleId IdType="pubmed">32265181</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalvez A. P., Engle R. E., St Claire M., Purcell R. H., Lai C. J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proceedings of the National Academy of Sciences of the United States of America . 2007;104(22):9422&#x2013;9427. doi: 10.1073/pnas.0703498104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0703498104</ArticleId><ArticleId IdType="pmc">PMC1868655</ArticleId><ArticleId IdType="pubmed">17517625</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A., Foo S.-S., Bruzzone R., Vu Dinh L., King N. J. C., Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunological Reviews . 2015;268(1):340&#x2013;364. doi: 10.1111/imr.12367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12367</ArticleId><ArticleId IdType="pmc">PMC7165974</ArticleId><ArticleId IdType="pubmed">26497532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn D. W., Green S., Kalayanarooj S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. The Journal of Infectious Diseases . 2000;181(1):2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Balsitis S. J., Coloma J., Castro G., et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. The American Journal of Tropical Medicine and Hygiene . 2009;80(3):416&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">19270292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K., Fong M. Y., Devi S., Lam S. K., Wong K. T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. The Journal of Infectious Diseases . 2004;189(8):1411&#x2013;1418. doi: 10.1086/383043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/383043</ArticleId><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A., Green S. Markers of dengue disease severity. In: Rothman A. L., editor. Dengue Virus . Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. pp. 67&#x2013;82.</Citation></Reference><Reference><Citation>Rothman A. L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nature Reviews. Immunology . 2011;11(8):532&#x2013;543. doi: 10.1038/nri3014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3014</ArticleId><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongkolsapaya J., Dejnirattisai W., Xu X. N., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nature Medicine . 2003;9(7):921&#x2013;927. doi: 10.1038/nm887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm887</ArticleId><ArticleId IdType="pubmed">12808447</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagan-Yasutan H., Ndhlovu L. C., Lacuesta T. L., et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. . 2013;58(4):635&#x2013;640. doi: 10.1016/j.jcv.2013.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.10.022</ArticleId><ArticleId IdType="pmc">PMC3880569</ArticleId><ArticleId IdType="pubmed">24239423</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra G., Mallik S., Saha B., Mukhopadhyay S. Assessment of chemokine and cytokine signatures in patients with dengue infection: a hospital-based study in Kolkata, India. Acta Tropica . 2019;190:73&#x2013;79. doi: 10.1016/j.actatropica.2018.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actatropica.2018.10.017</ArticleId><ArticleId IdType="pubmed">30395811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W. H., Lin C. Y., Chang K., et al. A clinical and epidemiological survey of the largest dengue outbreak in Southern Taiwan in 2015. International Journal of Infectious Diseases . 2019;88:88&#x2013;99. doi: 10.1016/j.ijid.2019.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.09.007</ArticleId><ArticleId IdType="pubmed">31521850</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Lee Y. H., Thein T. L., et al. Serum metabolomics reveals serotonin as a predictor of severe dengue in the early phase of dengue fever. PLoS Neglected Tropical Diseases . 2016;10(4, article e0004607) doi: 10.1371/journal.pntd.0004607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004607</ArticleId><ArticleId IdType="pmc">PMC4824427</ArticleId><ArticleId IdType="pubmed">27055163</ArticleId></ArticleIdList></Reference><Reference><Citation>Adikari T. N., Gomes L., Wickramasinghe N., et al. Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes. Clinical and experimental immunology. . 2016;184(1):90&#x2013;100. doi: 10.1111/cei.12747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12747</ArticleId><ArticleId IdType="pmc">PMC4778103</ArticleId><ArticleId IdType="pubmed">26621477</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T.-T., Chuang Y.-J., Lin Y.-S., et al. Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS neglected tropical diseases. . 2014;8(11):p. e3320-e. doi: 10.1371/journal.pntd.0003320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003320</ArticleId><ArticleId IdType="pmc">PMC4239119</ArticleId><ArticleId IdType="pubmed">25412261</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige G. N., Jeewandara C., Alles K. M., et al. Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS Neglected Tropical Diseases . 2013;7(9, article e2409) doi: 10.1371/journal.pntd.0002409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002409</ArticleId><ArticleId IdType="pmc">PMC3764236</ArticleId><ArticleId IdType="pubmed">24040431</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal T., Dutta S. K., Mandal S., Saha B., Tripathi A. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. . 2014;61(3):365&#x2013;370. doi: 10.1016/j.jcv.2014.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.09.003</ArticleId><ArticleId IdType="pubmed">25288310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T.-J., Chen C.-L., Jhan M.-K., Tseng P.-C., Lin C.-F. CNS immune profiling in a dengue virus-infected immunocompetent outbred ICR mice strain. Microbiology . 2020;10(517) doi: 10.3389/fcimb.2020.557610.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.557610</ArticleId><ArticleId IdType="pmc">PMC7539834</ArticleId><ArticleId IdType="pubmed">33072626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C.-C., Hong M.-Y., Ho T.-S., Liu C.-C., Perng G.-C., Chuang C.-C. Dynamic changes of soluble ST2 levels predicted fatality and were involved in coagulopathy in dengue fever in the elderly. PLOS Neglected Tropical Diseases. . 2019;13(12, article e0007974) doi: 10.1371/journal.pntd.0007974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007974</ArticleId><ArticleId IdType="pmc">PMC6948823</ArticleId><ArticleId IdType="pubmed">31877138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-R., Chao C.-H., Liu C.-C., et al. Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLOS Pathogens. . 2018;14(4, article e1007033) doi: 10.1371/journal.ppat.1007033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007033</ArticleId><ArticleId IdType="pmc">PMC6044858</ArticleId><ArticleId IdType="pubmed">29702687</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M. S., Roberts T. G., Edgil D., Lu B., Ernst J., Harris E. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. Journal of Virology . 2000;74(11):4957&#x2013;4966. doi: 10.1128/jvi.74.11.4957-4966.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.11.4957-4966.2000</ArticleId><ArticleId IdType="pmc">PMC110847</ArticleId><ArticleId IdType="pubmed">10799569</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S., Kyle J. L., Snider H. M., Basavapatna M., Beatty P. R., Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. Journal of Virology . 2004;78(6):2701&#x2013;2710. doi: 10.1128/jvi.78.6.2701-2710.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.6.2701-2710.2004</ArticleId><ArticleId IdType="pmc">PMC353772</ArticleId><ArticleId IdType="pubmed">14990690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle J. L., Harris E. Global spread and persistence of dengue. Annual Review of Microbiology . 2008;62:71&#x2013;92. doi: 10.1146/annurev.micro.62.081307.163005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.62.081307.163005</ArticleId><ArticleId IdType="pubmed">18429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe E. K., Leo Y.-S., Wong J. G. X., et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection [corrected] PLoS neglected tropical diseases. . 2014;8(4):p. e2777-e. doi: 10.1371/journal.pntd.0002777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002777</ArticleId><ArticleId IdType="pmc">PMC3974675</ArticleId><ArticleId IdType="pubmed">24699282</ArticleId></ArticleIdList></Reference><Reference><Citation>Abualamah W. A., Banni H. S., Almasmoum H. A., Allohibi Y. A., Samarin H. M., Bafail M. A. Determining risk factors for dengue fever severity in Jeddah City, a case-control study (2017) Polish Journal of Microbiology . 2020;69(3):331&#x2013;337. doi: 10.33073/pjm-2020-036.</Citation><ArticleIdList><ArticleId IdType="doi">10.33073/pjm-2020-036</ArticleId><ArticleId IdType="pmc">PMC7810113</ArticleId><ArticleId IdType="pubmed">33574862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J., Salim A., Lee V. J., et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS neglected tropical diseases. . 2012;6(5):p. e1641-e. doi: 10.1371/journal.pntd.0001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001641</ArticleId><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Maneekan P., Leaungwutiwong P., Misse D., Luplertlop N. T helper (Th) 1 and Th2 cytokine expression profile in dengue and malaria infection using magnetic bead-based bio-plex assay. The Southeast Asian Journal of Tropical Medicine and Public Health . 2013;44(1):31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">23682435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta V. K., Verma R., Garg R. K., Malhotra H. S., Sharma P. K., Jain A. Study of interleukin-6 and interleukin-8 levels in patients with neurological manifestations of dengue. Journal of Postgraduate Medicine . 2017;63(1):11&#x2013;15. doi: 10.4103/0022-3859.188545.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0022-3859.188545</ArticleId><ArticleId IdType="pmc">PMC5394810</ArticleId><ArticleId IdType="pubmed">28079042</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyadarshini D., Gadia R. R., Tripathy A., et al. Clinical findings and proinflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One . 2010;5(1, article e8709-e) doi: 10.1371/journal.pone.0008709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008709</ArticleId><ArticleId IdType="pmc">PMC2806829</ArticleId><ArticleId IdType="pubmed">20090849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi U. C., Agarwal R., Elbishbishi E. A., Mustafa A. S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunology and Medical Microbiology . 2000;28(3):183&#x2013;188. doi: 10.1111/j.1574-695X.2000.tb01474.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2000.tb01474.x</ArticleId><ArticleId IdType="pubmed">10865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestwood T. R., Morar M. M., Zellweger R. M., et al. Gamma interferon (IFN-&#x3b3;) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-&#x3b1;/&#x3b2; receptor-deficient mice. Journal of Virology . 2012;86(23):12561&#x2013;12570. doi: 10.1128/JVI.06743-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06743-11</ArticleId><ArticleId IdType="pmc">PMC3497655</ArticleId><ArticleId IdType="pubmed">22973027</ArticleId></ArticleIdList></Reference><Reference><Citation>Htun N. S. N., Odermatt P., Eze I. C., Boillat-Blanco N., D&#x2019;Acremont V., Probst-Hensch N. Is diabetes a risk factor for a severe clinical presentation of dengue?- Review and meta-analysis. PLOS Neglected Tropical Diseases. . 2015;9(4, article e0003741) doi: 10.1371/journal.pntd.0003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003741</ArticleId><ArticleId IdType="pmc">PMC4409149</ArticleId><ArticleId IdType="pubmed">25909658</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C. C., Cia C. T., Lee J. C., et al. A cohort study of adult patients with severe dengue in Taiwanese intensive care units: the elderly and APTT prolongation matter for prognosis. PLoS Neglected Tropical Diseases . 2017;11(1, article e0005270) doi: 10.1371/journal.pntd.0005270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005270</ArticleId><ArticleId IdType="pmc">PMC5245902</ArticleId><ArticleId IdType="pubmed">28060934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. M., Chan K. S., Yu W. L., et al. The outcomes of patients with severe dengue admitted to intensive care units. Medicine (Baltimore) . 2016;95(31, article e4376) doi: 10.1097/MD.0000000000004376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004376</ArticleId><ArticleId IdType="pmc">PMC4979801</ArticleId><ArticleId IdType="pubmed">27495047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza F. A., Cruz O. G., Zagne S. M. O., et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infectious Diseases . 2008;8(1) doi: 10.1186/1471-2334-8-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-86</ArticleId><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong Y. K., Tan H. Y., Jen S. H., et al. Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease. Journal of Translational Medicine . 2017;15(1):p. 121. doi: 10.1186/s12967-017-1226-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1226-4</ArticleId><ArticleId IdType="pmc">PMC5452397</ArticleId><ArticleId IdType="pubmed">28569153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa A. S., Elbishbishi E. A., Agarwal R., Chaturvedi U. C. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunology &amp; Medical Microbiology . 2001;30(3):229&#x2013;233. doi: 10.1111/j.1574-695X.2001.tb01575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2001.tb01575.x</ArticleId><ArticleId IdType="pubmed">11335143</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick D., Schwartsburd B., Pinkus R., et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine . 2001;14(6):334&#x2013;342. doi: 10.1006/cyto.2001.0914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2001.0914</ArticleId><ArticleId IdType="pubmed">11497494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaharieva E., Kamenov Z., Velikova T., Tsakova A., El-Darawish Y., Okamura H. Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. Endocrine Connections . 2018;7(1):179&#x2013;185. doi: 10.1530/EC-17-0273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-17-0273</ArticleId><ArticleId IdType="pmc">PMC5776671</ArticleId><ArticleId IdType="pubmed">29217651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung J., McQuillan B. M., Chapman C. M. L., Thompson P. L., Beilby J. P. Elevated Interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology. . 2005;25(6):1268&#x2013;1273. doi: 10.1161/01.ATV.0000163843.70369.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000163843.70369.12</ArticleId><ArticleId IdType="pubmed">15790931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xf8;seid M., Seljeflot I., Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovascular Diabetology . 2010;9(1):p. 11. doi: 10.1186/1475-2840-9-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2840-9-11</ArticleId><ArticleId IdType="pmc">PMC2858122</ArticleId><ArticleId IdType="pubmed">20331890</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallat Z., Corbaz A., Scoazec A., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation . 2001;104(14):1598&#x2013;1603. doi: 10.1161/hc3901.096721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3901.096721</ArticleId><ArticleId IdType="pubmed">11581135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat O., Dhawan V. Role of IL-18 and its signaling in atherosclerosis. Inflammation and Cell Signaling . 2015;2(1) doi: 10.14800/ics.707.</Citation><ArticleIdList><ArticleId IdType="doi">10.14800/ics.707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C. H., Wu W. C., Lai Y. C., et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathogens . 2019;15(4, article e1007625) doi: 10.1371/journal.ppat.1007625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007625</ArticleId><ArticleId IdType="pmc">PMC6497319</ArticleId><ArticleId IdType="pubmed">31009511</ArticleId></ArticleIdList></Reference><Reference><Citation>Allam O., Samarani S., Jenabian M. A., et al. Differential synthesis and release of IL-18 and IL-18 binding protein from human platelets and their implications for HIV infection. Cytokine . 2017;90:144&#x2013;154. doi: 10.1016/j.cyto.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2016.10.016</ArticleId><ArticleId IdType="pubmed">27914933</ArticleId></ArticleIdList></Reference><Reference><Citation>Scull C. M., Hays W. D., Fischer T. H. Macrophage proinflammatory cytokine secretion is enhanced following interaction with autologous platelets. Journal of Inflammation . 2010;7(1):p. 53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988777</ArticleId><ArticleId IdType="pubmed">21067617</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi P., Chaturvedi U. C., Mukherjee R. Transmission of dengue virus-induced helper signal to B cell via macrophages. International Journal of Experimental Pathology . 1992;73(6):773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2002438</ArticleId><ArticleId IdType="pubmed">1493106</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S., Kyle J. L., Robert Beatty P., Harris E. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology . 2004;319(2):262&#x2013;273. doi: 10.1016/j.virol.2003.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2003.09.048</ArticleId><ArticleId IdType="pubmed">14980486</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S. B., Mahalingam S., Marovich M. A., Ubol S., Mosser D. M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. The Lancet infectious diseases. . 2010;10(10):712&#x2013;722. doi: 10.1016/S1473-3099(10)70166-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70166-3</ArticleId><ArticleId IdType="pmc">PMC3057165</ArticleId><ArticleId IdType="pubmed">20883967</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S., Venkateshan C., Gentry M., Larsen L. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. The Journal of Immunology . 1984;132(3):1529&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pubmed">6607288</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>